Oil prices edged up on Friday, on track to rise at their steepest rate since early June as Ukraine's attacks on Russia's energy infrastructure push Moscow to restrict fuel exports and close to cutting ...

In the last three months, 7 analysts have published ratings on Acadia Healthcare Co (NASDAQ:ACHC), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find a ...

The price points we guessed at for GM’s new trio of full-size crossovers seem to be coming true. Saturn’s upcoming Outlook — out near the end of the year — will start at $27,990. That’s a full $2,000 ...

Acadia’s management has outlined potential peak sales of $1.5-2.0 billion for its Nuplazid and Daybue products, along with risk-adjusted peak sales of $2.5 billion for pipeline assets. The full peak ...

Acadia reported the complete set of data from its Harmony study. The results are clearly positive for the company. The opportunity for the company appears to be very large. Looking for a helping hand ...

The first hit vehicles of 2007 have arrived. The Saturn Outlook and GMC Acadia, GM’s new fuel-efficient and family friendly SUVs that are essentially twins, have the looks, practicality, comfort and ...

Acadia's Q1 2023 financials demonstrate marginal improvement when compared to the same period in 2022, with a slight increase in net product sales and notable cost reduction. Liquidity position ...

Investing.com -- Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares plunged 12.4% in after-hours trading Wednesday after the behavioral healthcare provider cut its full-year financial guidance ...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on developing and commercializing innovative medicines for central nervous system (CNS) disorders, finds itself at a ...